$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

System of components for preparing oligonucleotides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12P-019/34
  • C12P-019/00
  • G06F-019/00
  • C12Q-001/68
출원번호 US-0067638 (1998-04-28)
등록번호 US-7321828 (2008-01-22)
발명자 / 주소
  • Cowsert,Lex M.
  • Baker,Brenda F.
  • McNeil,John
  • Freier,Susan M.
  • Sasmor,Henri M.
  • Brooks,Douglas G.
  • Ohashi,Cara
  • Wyatt,Jacqueline R.
  • Borchers,Alexander H.
  • Vickers,Timothy A.
출원인 / 주소
  • Isis Pharmaceuticals, Inc.
인용정보 피인용 횟수 : 147  인용 특허 : 200

초록

Interative, preferably computer based iterative processes for generating synthetic compounds with desired physical, chemical and/or bioactive properties, i.e., active compounds, are provided. During iterations of the processes, a target nucleic acid sequence is provided or selected, and a library of

대표청구항

What is claimed is: 1. A system of associated components for preparing a set of oligonucleotides that modulates expression of a selected nucleic acid comprising: a computer system that i) generates a list of oligonucleotide sequences according to a desired oligonucleotide length, thereby generating

이 특허에 인용된 특허 (200)

  1. Tkachuk Zenovy (Kiev SUX) Kvasyuk Eugeny (Kiev SUX) Matsuka Gennady (Kiev SUX) Mikhailopulo Igor (Kiev SUX), (2′-5′) oligoadenylate analogues useful as inhibitors of host-v5.-graft response.
  2. Dhanoa, Daljit S.; Doller, Dario; Meegalla, Sanath; Soll, Richard M.; Wisnewski, Nancy; Silver, Gary; Stinchcomb, Dan T.; Seward, R. Lee; Agrafiotis, Dimitris; Sha, Deyou, 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides.
  3. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  4. Huynh Dinh Tam (Croissy/Seine FRX) Gouyette Catherine (Vanves FRX) Igolen Jean (Le Mesnil St. Denis FRX), 2,N6-disubstituted and 2,N6-trisubstituted adenosine-3′-phosphoramidites.
  5. Buhr Chris A. (Daly City CA) Matteucci Mark (Burlingame CA), 2\modified nucleoside and nucleotide compounds.
  6. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 2′,5′-phosphorothioate oligoadenylates and their covalent conjugates with polylysine.
  7. Montgomery John A. (Birmingham AL) Secrist ; III John A. (Birmingham AL), 2′-deoxy-4′-thioribonucleosides and their antiviral activity.
  8. Usman Nassim (Boulder CO) Karpeisky Alexander (Boulder CO) Beigelman Leonid (Longmont CO) Modak Anil (Boulder CO), 2′deoxy-2′-alkylnucleotide containing nucleic acid.
  9. Peyman Anuschirwan (Kelkheim DEX) Uhlmann Eugen (Glashutten DEX) Carolus Carolin (Frankfurt DEX), 3\-modified oligonucleotide derivatives.
  10. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), 4′-desmethyl nucleoside analog compounds.
  11. Albertsen Hans (Salt Lake City UT) Anand Rakesh (Cheshire UT GB2) Carlson Mary (Salt Lake City UT) Groden Joanna (Salt Lake City UT) Hedge Philip J. (Cheshire UT GB2) Joslyn Geoff (Salt Lake City UT), APC gene and nucleic acid probes derived therefrom.
  12. Cook Philip D. (Carlsbad CA) Delecki Daniel J. (Radnor PA) Guinosso Charles (Vista CA), Acyclic nucleoside analogs and oligonucleotide sequences containing them.
  13. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR) Stirchak Eugene P. (Corvallis OR), Alpha-morpholino ribonucleoside derivatives and polymers thereof.
  14. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphorothioamidate oligonucleotide deratives.
  15. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphotriester oligonucleotide derivatives.
  16. Graybill Todd L. ; Wu Zhengdong ; Subasinghe Nalin ; Fedde Cynthia L. ; Salvino Joseph M., Aminobenzenedicarboxylic acid-based combinatorial libraries.
  17. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Anthraquinone-derivatives oligonucleotides.
  18. Switzer Christopher (Moreno Valley CA), Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides.
  19. Southern Edwin (Oxford GB2), Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays.
  20. Brennan Thomas M. (San Francisco CA), Apparatus and method for polymer synthesis using arrays.
  21. Brennan Thomas M. (San Francisco CA), Apparatus and method for polymer synthesis using arrays.
  22. Harris Paul C. (Edmonds WA) Genstler Curtis C. (Redmond WA), Automated patient sample analysis instrument having tubes and reaction wells washing apparatus.
  23. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  24. De Mesmaeker Alain (Kaenerkinden CHX) Lebreton Jacques (Marseilles FRX) Waldner Adrian (Allschwil CHX) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  25. Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling.
  26. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Morvan Francois (Montpellier FRX), Backbone modified oligonucleotide analogs and solid phase synthesis thereof.
  27. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  28. Sanghvi Yogesh S. (San Marcos CA) Cook Phillip D. (Vista CA), Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling.
  29. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  30. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  31. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  32. Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same.
  33. Spielvogel Bernard F. (107 Wood Glen Dr. Cary NC 27511) Sood Anup (5041 Gatewood Dr. Durham NC 27712), Boronated phosphoramidate compounds.
  34. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  35. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  36. Letsinger Robert L. (Wilmette IL), Cholesteryl modified oligonucleotides.
  37. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent (Austin TX), Chromophore probe for detection of nucleic acid.
  38. Bertsch-Frank Birgit (Rheinfelden DEX) Klasen Claas-Juergen (Freigericht DEX) Lieser Thomas (Hapau DEX) Mueller Klaus (Hasselroth DEX) Bewersdorf Martin (Gelnhausen DEX), Coated sodium percarbonate particles, a process for their production and detergent, cleaning and bleaching compositions.
  39. Snitman David L. (Boulder CO), Compositions and methods for functionalizing nucleic acids.
  40. Kmiec Eric B. (Malvern PA), Compounds and methods for site directed mutations in eukaryotic cells.
  41. Ohtsuka Eiko (Sappro JPX) Inoue Hideo (Sappro JPX) Morisawa Hirokazu (Kawasaki JPX) Shibahara Susumu (Kawasaki JPX) Mukai Sachiko (Kawasaki JPX) Nishihara Tohru (Kurashiki JPX), Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and st.
  42. Hubbell Earl A. (Mt. View CA) Morris MacDonald S. (San Jose CA) Winkler James L. (Palo Alto CA), Computer-aided engineering system for design of sequence arrays and lithographic masks.
  43. Hubbell Earl A. ; Morris MacDonald S. ; Winkler James L., Computer-aided engineering system for design of sequence arrays and lithographic masks.
  44. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  45. Linn C. Preston (Durham NC) Pitner J. Bruce (Durham NC) Mize Pat D. (Durham NC), Covalent cyanine dye oligonucleotide conjugates.
  46. Cook Phillip D. (Carlsbad CA) Baschang Gerhard (Bettingen CHX), Cyclobutyl oligonucleotide surrogates.
  47. Cutting Garry R. (Towson MD) Antonarakis Stylianos E. (Lutherville MD) Kazazian ; Jr. Haig H. (Baltimore MD), Cystic fibrosis mutation cluster.
  48. Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA) Kaiser ; Jr. Robert J. (Glendale CA), DNA-reporter conjugates linked via the 2′or 5′-primary amino group of the 5′-terminal nucleoside.
  49. Blatter Harold ; Horlander Thomas Edward ; Bridgewater Kevin Elliott ; Deiss Michael Scott, Decoding system and data format for processing and storing encrypted broadcast, cable or satellite video data.
  50. Rice Bart F. (Santa Cruz CA), Detection of a multi-sequence spread spectrum signal.
  51. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) De Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel C, Dinucleoside phosphinates and their pharmaceutical compositions.
  52. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), Dual action 2′,5′-oligoadenylate antiviral derivatives and uses thereof.
  53. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Encapsulated 2′,5′-phosphorothioate oligoadenylates.
  54. Brakel Christine L. (Brightwaters NY) Cook Alan F. (Cedar Groove NJ) Vuocolo Edmund (Bronx NY), End labeled nucleotide probe.
  55. Froehler Brian (Belmont CA) Matteucci Mark (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified purines.
  56. Weis Alexander L. (Berwyn PA) Oakes Fred T. (Rochester NY) Hausheer Frederick H. (San Antonio TX) Cavanaugh ; Jr. Paul F. (West Chester PA) Moskwa Patricia S. (Phoenixville PA), Exonuclease resistant terminally substituted oligonucleotides.
  57. Froehler Brian C. (Belmont CA), Exonuclease-resistant oligonucleotides.
  58. Brush Charles K. (Whitefish Bay WI), Fluorescein labelled phosphoramidites.
  59. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  60. Cook Phillip D. (Vista CA) Monia Brett P. (Carlsbad CA), Gapped 2′modified oligonucleotides.
  61. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Heteroatomic oligonucleoside linkages.
  62. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  63. Mallion Keith B. (Knutsford GB2), Heterocyclic derivatives.
  64. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  65. Rogers Thomas E. (Manchester MO) Gray Steven H. (Ellisville MO) Devadas Balekudru (Chesterfield MO) Adams Steven P. (St. Charles MO), Improved probes using nucleosides containing 3-dezauracil analogs.
  66. Goodchild John (Worcester MA) Zamecnik Paul C. (Shrewsbury MA), Inhibition of HTLV-III by exogenous oligonucleotides.
  67. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  68. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  69. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  70. Ecker David J. (Leucadia CA) Wyatt Jacqueline R. (Carlsbad CA) Imbach Jean L. (Montpellier FRX), Inhibitors of human immunodeficiency virus.
  71. Agrawal Sudhir (Shrewsbury MA), Inverted chimeric and hybrid oligonucleotides.
  72. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Linear aminoalkylphosphoramidate oligonucleotide derivatives.
  73. Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Linkage of proteins to nucleic acids.
  74. Arnold ; Jr. Lyle J. (San Diego CA) Reynolds Mark A. (San Diego CA) Bhatt Ram S. (San Diego CA), Linking reagents for nucleotide probes.
  75. Brown Richard Hunter (Chesham GB2), Liquid level sensor.
  76. Benner Steven A. (Hadlaubstrasse 151 CH-8006 Zurich CHX), Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases.
  77. Edwards Cynthia A. ; Fry Kirk E. ; Cantor Charles R. ; Andrews Beth M., Method of constructing sequence-specific DNA-binding molecules.
  78. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent L. (Austin TX) Sansom Petra I. (Austin TX) Crofts Shaun P. (Campbell CA), Method of expanded porphyrin-oligonucleotide conjugate synthesis.
  79. Dimitris K. Agrafiotis ; Roger F. Bone ; Francis R. Salemme ; Richard M. Soll, Method of generating chemical compounds having desired properties.
  80. Edwards Cynthia A. (Menlo Park CA) Fry Kirk E. (Palo Alto CA) Cantor Charles R. (Boston MA) Andrews Beth M. (Maynard MA 4), Method of ordering sequence binding preferences of a DNA-binding molecule.
  81. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  82. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  83. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  84. Hasson Harrith M. (2043 N. Sedwick Chicago IL 60614), Method of suspending a pelvic organ and instrument for performing the method.
  85. Agrafiotis, Dimitris K.; Lobanov, Victor S.; Salemme, Francis R., Method, system and computer program product for non-linear mapping of multi-dimensional data.
  86. Agrafiotis Dimitris K. ; Lobanov Victor S. ; Salemme Francis R., Method, system, and computer program product for representing similarity/dissimilarity between chemical compounds.
  87. Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA) Eder Paul S. (Iowa City IA) Dagle John M. (Iowa City IA), Methods for blocking the expression of specifically targeted genes.
  88. Peterson Todd C. ; Foster Lyndon M. ; Brian Paul, Methods for generating and screening novel metabolic pathways.
  89. Thompson Katie A. ; Foster Lyndon M. ; Peterson Todd C. ; Nasby Nicole Marie ; Brian Paul, Methods for generating and screening novel metabolic pathways.
  90. Cook Phillip Dan (Vista CA) Teng Kelly (San Diego CA), Methods of making conjugated 4′desmethyl nucleoside analog compounds.
  91. Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  92. Pieles Uwe (Gttingen DEX) Englisch Uwe (Gttingen DEX) Cramer Friedrich (Gttingen DEX), Modified oligonucleotides.
  93. Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  94. Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Multifunctional nucleic acid monomer.
  95. Cook P. Dan (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), N-2 substituted purines.
  96. Chang Chu-An (Piedmont CA) Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith.
  97. Chang Chu-An (Piedmont CA) Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith.
  98. Nelson Paul S. (Union City CA) Kent Mark A. (Sunnyvale CA), Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides.
  99. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods.
  100. Shizuya Hiroaki (1632 Indiana Ave. South Pasadena CA 91030) Millar Sharon L. (1825 Lanai St. West Covina CA 91792), Non-radioisotope tagging of fragments.
  101. Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  102. Tullis Richard H. (Leucadia CA), Novel amphiphilic nucleic acid conjugates.
  103. Nguyen Thanh T. (Tigy FRX) Helene Claude (Saint Cyr en Val FRX) Asseline Ulysse (La Source FRX), Novel compounds containing an oligonucleotide sequence bonded to an intercalating agent, a process for their synthesis a.
  104. Hoey Timothy (Woodside CA), Nuclear factors and binding assay.
  105. Hoey Timothy, Nuclear factors and binding assays.
  106. Weis Alexander L. (Berwyn PA) Oakes Fred T. (Rochester NY) Hausheer Frederick H. (San Antonio TX) Cavanaugh ; Jr. Paul F. (West Chester PA) Moskwa Patricia S. (Phoenixville PA), Nuclease resistant compounds.
  107. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression.
  108. Haff Lawrence A. ; Picozza Enrico ; Bloch Will ; Ragusa Robert ; DiCesare Joseph ; Tracy David ; Saviano Paul ; Woudenberg Timothy M., Nucleic acid amplification reaction apparatus.
  109. Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA), Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled.
  110. Bischofberger Norbert W. (San Carlos CA) Matteucci Mark D. (Burlingame CA), Nucleic acid intercalating agents.
  111. Ramachandran Kuzhalmannam L. (Natick MA) Cate Richard L. (Plymouth MA), Nucleic acid probe linked to a label having a terminal cysteine.
  112. Rokita Steven E. (Port Jefferson NY) Chatterjee Moneesh (Stony Brook NY), Nucleic acids labeled with naphthoquinone probe.
  113. Haralambidis Jim (Victoria AUX), Nucleoside derivatives.
  114. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel CHX), Nucleoside phosphinate compounds and compositions.
  115. Klevan Leonard (Washington DC) Gebeyehu Gulilat (Silver Spring MD) Rao Prasad Y. (Damascus MD), Nucleotide analogs for nucleic acid labeling and detection.
  116. Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Nucleotides for introducing selectably cleavable and/or abasic sites into oligonucleotides.
  117. Meyer ; Jr. Rich B. (Woodinville WA) Adams A. David (Snohomish WA) Petrie Charles R. (Woodinville WA), Oligo (aa 상세보기
  • Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  • Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  • Hecht Sidney M. (Charlottesville VA), Oligonucleotide N-alkylphosphoramidates.
  • Bischofberger Norbert (San Carlos CA) Kent Ken (Mountain View CA) Wagner Rick (Burlingame CA) Buhr Chris (Daly City CA) Lin Kuei-Ying (Fremont CA), Oligonucleotide analogs capable of passive cell membrane permeation.
  • Benner Steven A. (Grossmannstrasse 16 ; #7 CH-8049 Zurich CHX), Oligonucleotide analogs containing sulfur linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Huie Edward M. (Wilmington DE) Trainor George L. (Wilmington DE), Oligonucleotide analogs with sulfamate linkages.
  • Weis Alexander Ludvik (Berwyn PA) Hausheer Frederick Herman (San Antonio TX) Chaturvedula Prasad Venkata Chala (Exton PA) Delecki Daniel Joseph (Radnor PA) Cavanaugh ; Jr. Paul Francis (West Chester , Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleo.
  • Priest John H. (Everett WA), Oligonucleotide conjugates.
  • Miyoshi Kenichi (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives.
  • Miyoshi Kenichi (Hiroshima JPX) Suzuki Masanori (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives.
  • Miyoshi Kenichi (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives and production thereof.
  • Chaturvedula Prasad Venkata Chala (Exton PA), Oligonucleotide dimers with amide linkages replacing phosphodiester linkages.
  • Buhr Chris A. (Daly City CA), Oligonucleotide having enhanced binding affinity.
  • Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Worcester MA), Oligonucleotide multiple reporter precursors.
  • Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  • Warren ; III Harold C. (Rush NY) Oakes Fred T. (Rochester NY), Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction proce.
  • Hornes Erik (Oslo NOX) Korsnes Lars (Oslo NOX), Oligonucleotide-linked magnetic particles and uses thereof.
  • Haralambidis Jim (Box Hill South AUX) Tregear Geoffrey W. (Hawthorn AUX), Oligonucleotide-polyamide conjugates and methods of production and applications of the same.
  • Maag Hans (Menlo Park CA) Rose Samuel J. (Mountain View CA) Schmidt Beat (Baltschieder CHX), Oligonucleotides containing 4′-substituted nucleotides.
  • Gmeiner William H. (Omaha NE) Iversen Patrick L. (Omaha NE), Oligonucleotides containing 5-fluorouracil.
  • Froehler Brian (Belmont CA) Jones Robert J. (Daly City CA), Oligonucleotides containing 5-propynyl pyrimidines.
  • Cook Phillip D. (San Marcos CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), Oligonucleotides containing N-2 substituted purines.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA) Kaiser ; Jr. Robert J. (Glendale CA), Oligonucleotides possessing a primary amino group in the terminal nucleotide.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Oligonucleotides with cleavable sites.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Lebleu Bernard (Montpellier FRX) Bayard Bernard (Castelnau Le Lez FRX), Oligonucleotides with modified phosphate and modified carbohydrate moieties at the respective chain termini.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Oligonucleotides with selectably cleavable and/or abasic sites.
  • Imbach Jean-Louis (Montpellier FRX) Gosselin Gilles J. M. (Montpellier FRX), Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Shaw Barbara R. (Durham NC), Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Barascut Jean-Louis (Combaillaux FRX) Imbach Jean-Louis (Montpellier FRX), Oligothionucleotides.
  • Cook Phillip Dan (Carlsbad CA), PNA-DNA-PNA chimeric macromolecules.
  • Meyer ; Jr. Rich B. (Woodinville WA) Gall Alexander A. (Bothell WA) Reed Michael W. (Seattle WA), Peptide linkers for improved oligonucleotide delivery.
  • Nielsen Peter E. (Hjortevanget 509 DK 2980 Kokkedal DKX) Buchardt Ole (Sondergardsvej 73 DK 3500 Vaerlose DKX) Egholm Michael (Johnstrup Alle 3 DK 1923 Frederiksberg DKX) Berg Rolf H. (Strandvaenget , Peptide nucleic acids.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; legal representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having amino acid side chains.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility.
  • Misiura Konrad (Lodz PLX) Gait Michael (Cambridge GB3), Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Photolabile reagents for incorporation into oligonucleotide chains.
  • Yamane Akio (Hiroshima JPX) Kawasoe Tatsuro (Hiroshima JPX) Tsukumo Noriko (Hiroshima JPX) Miyoshi Kenichi (Hiroshima JPX), Poly-labelled oligonucleotide derivative.
  • Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  • Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  • Maddry Joseph A. (Birmingham AL) Reynolds Robert C. (Birmingham AL) Secrist John A. (Birmingham AL) Montgomery John A. (Birmingham AL) Crooks Peter A. (Lexington KY), Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use.
  • Mullis Kary B. (La Jolla CA) Erlich Henry A. (Oakland CA) Arnheim Norman (Woodland Hills CA) Horn Glenn T. (Emeryville CA) Saiki Randall K. (Richmond CA) Scharf Stephen J. (Berkeley CA), Process for amplifying, detecting, and/or cloning nucleic acid sequences.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • McGee Daniel Peter Claude (Boulder CO), Process for the preparation of 2′-O-alkyl purine phosphoramidites.
  • Weis Alexander L. (Berwyn PA) Saha Ashis K. (Frazer PA) Hausheer Frederick H. (San Antonio TX), Process of linking nucleosides with a siloxane bridge.
  • Hawkins Mary E. (Potomac MD) Pfleiderer Wolfgang (Konstanz MD DEX) Davis Michael D. (Rockville MD) Balis Frank (Bethesda MD), Pteridine nucleotide analogs as fluorescent DNA probes.
  • Matteucci Mark D. (Burlingame CA) Jones Robert J. (Millbrae CA) Lin Kuei-Ying (Fremont CA), Pyrimidine derivatives for labeled binding partners.
  • Acevedo Oscar L. (San Diego CA) Hebert Normand (San Marcos CA), Pyrrolidine-containing monomers and oligomers.
  • Hobbs ; Jr. Frank W. (Wilmington DE), Reagents for the preparation of 5′-tagged oligonucleotides.
  • Haseloff James P. (O\Connor AUX) Gerlach Wayne L. (Hughes AUX) Jennings Philip A. (West Chatswood AUX) Cameron Fiona H. (Forestville AUX), Ribozymes.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Ruth Jerry L. (San Diego CA), Single-stranded labelled oligonucleotides of preselected sequence.
  • Ruth Jerry L. (San Diego CA), Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis.
  • Agrawal, Sudhir; Tang, Jinyan, Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling.
  • Van Ness Jeffrey (Bothell WA) Petrie Charles R. (Woodinville WA) Tabone John C. (Bothell WA) Vermeulen Nicolaas M. J. (Woodinville WA), Solid supports for nucleic acid hybridization assays.
  • Gordon Julian (307 E. Sheridan Rd. Lake Bluft IL 60044) Minks Michael A. (Biochemistry Dept. ; University of the Witwatersrand ; 1 Jan Smuts Ave Johannesburg 2001 ZAX), Specific antibody to the native form of 2′5′-oligonucleotides, the method of preparation and the use as reagents in im.
  • Letsinger Robert L. (Wilmetter IL), Steroid modified oligonucleotides.
  • Cook Phillip Dan (Carlsbad CA) Manoharan Muthiah (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA), Substituted purines and oligonucleotide cross-linking.
  • Cook Phillip Dan (Carlsbad CA) Kawasaki Andrew Mamoro (Oceanside CA), Sugar modified oligonucleotides that detect and modulate gene expression.
  • Southern Edwin M. (Oxford GB3) Maskos Uwe (Oxford GB3), Support-bound oligonucleotides.
  • Dower William J. (Menlo Park CA) Barrett Ronald W. (Sunnyvale CA) Gallop Mark A. (Palo Alto CA) Needels Michael C. (Oakland CA), Synthesizing and screening molecular diversity.
  • Agrafiotis Dimitris K. (Exton PA) Bone Roger F. (Bridgewater NJ) Salemme Francis R. (Kennett Square PA) Soll Richard M. (Lawrenceville NJ), System and method of automatically generating chemical compounds with desired properties.
  • Agrafiotis Dimitris K. (Exton PA) Bone Roger F. (Bridgewater NJ) Salemme Francis R. (Kennett Square PA) Soll Richard M. (Lawrenceville NJ), System and method of automatically generating chemical compounds with desired properties.
  • Dimitris K. Agrafiotis ; Roger F. Bone ; Francis R. Salemme ; Richard M. Soll, System, method and computer program product for identifying chemical compounds having desired properties.
  • Agrafiotis Dimitris K. (Exton PA) Bone Roger F. (Bridgewater NJ) Salemme Francis R. (Kennett Square PA) Soll Richard M. (Lawrenceville NJ), System, method, and computer program for at least partially automatically generating chemical compounds having desired p.
  • Agrafiotis Dimitris K. ; Bone Roger F. ; Salemme Francis R. ; Soll Richard M., System, method, and computer program product for at least partially automatically generating chemical compounds with des.
  • Dimitris K. Agrafiotis ; Victor S. Labanov ; Francis R. Salemme, System, method, and computer program product for representing proximity data in a multi-dimensional space.
  • Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA), Texaphyrin compounds having improved functionalization.
  • Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA), Texaphyrin metal complexes having improved functionalization.
  • Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA) Kral Vladimir A. (Austin TX) Magda Darren (Cupertino CA), Texaphyrin-oligonucleotide conjugates.
  • Cook Phillip D. (Carlsbad CA) Manoharan Muthiah (Carlsbad CA), Thiol-derivatized nucleosides.
  • Peterson Michael G. (So. San Francisco CA) Baichwal Vijay R. (So. San Francisco CA) Strulovici Berta (So. San Francisco CA), Transcription factor-DNA binding assay.
  • Reed Michael W. (3575 NE. 180th Seattle WA 98105) Meyer ; Jr. Rich B. (15411 NE. 176th Pl. Woodinville WA 98072), Trifunctional intermediates for preparing 3′-tailed oligonucleotides.
  • Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages.
  • Dhanoa, Daljit S.; Doller, Dario; Meegalla, Sanath; Soll, Richard M.; Agrafiotis, Dimitris; Wisnewski, Nancy; Silver, Gary M.; Stinchcomb, Dan T.; Seward, R. Lee, Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides.
  • 이 특허를 인용한 특허 (147)

    1. Collard, Joseph; Khorkova Sherman, Olga; De Leon, Belinda, Antagonat compositions and methods of use.
    2. Dabrowski, Paul; Dabrowski, Michael; Gerlinghaus, Fabian; Pesch, Alex, Automated modular system and method for production of biopolymers.
    3. Sampath, Rangarajan, Compositions for use in identification of adventitious viruses.
    4. Sampath, Rangarajan; Hall, Thomas A.; Eshoo, Mark W., Compositions for use in identification of alphaviruses.
    5. Sampath, Rangarajan; Hall, Thomas A.; Ecker, David J.; Blyn, Lawrence, Compositions for use in identification of bacteria.
    6. Sampath, Rangarajan; Hall, Thomas A.; Ecker, David J.; Hofstadler, Steven A., Compositions for use in identification of orthopoxviruses.
    7. Hofstadler, Steven A.; Gutierrez, Jose R.; Hannis, James C.; Drader, Jared J.; Bare, Rex O.; Smith, Jeffrey C.; Gleason, Paul J.; Nathanson, Jared, Ionization probe assemblies.
    8. Hofstadler, Steven A.; Gutierrez, Jose R.; Hannis, James C.; Drader, Jared J.; Bare, Rex O.; Smith, Jeffrey C.; Gleason, Paul J.; Nathanson, Jared, Ionization probe assemblies.
    9. Hofstadler, Steven A.; Gutierrez, Jose R.; Hannis, James C.; Drader, Jared J.; Bare, Rex O.; Smith, Jeffrey C.; Gleason, Paul J.; Nathanson, Jared, Ionization probe assemblies.
    10. Drader, Jared J.; Hofstadler, Steven A.; Gutierrez, Jose R.; Gleason, Paul J.; Scherer, Andrew J.; Bare, Rex O., Lift and mount apparatus.
    11. Hofstadler, Steven A.; Drader, Jared J.; Schink, Amy L., Mass spectrometry with selective ion filtration by digital thresholding.
    12. Hofstadler, Steven A.; Drader, Jared J.; Schink, Amy L., Mass spectrometry with selective ion filtration by digital thresholding.
    13. Hofstadler, Steven A.; Drader, Jared J.; Schink, Amy L., Mass spectrometry with selective ion filtration by digital thresholding.
    14. Hofstadler, Steven A.; Drader, Jared J.; Schink, Amy L., Mass spectrometry with selective ion filtration by digital thresholding.
    15. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John, Method for rapid detection and identification of bioagents.
    16. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John, Method for rapid detection and identification of bioagents.
    17. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John, Method for rapid detection and identification of bioagents.
    18. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven; McNeil, John, Method for rapid detection and identification of bioagents.
    19. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven; McNeil, John, Method for rapid detection and identification of bioagents.
    20. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Hannis, James C., Method for rapid detection and identification of bioagents in epidemiological and forensic investigations.
    21. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Sofianos, Dino J.; Rudnick, Karl H.; Knize, Duane J.; Stoughton, Roland B.; Basham, Jr., Cecil L.; Lewis, Clifford T.; Larson, Brons M.; Bar-on, Jonathan R.; Murray, Dennis P.; Robbins, David W.; Penhune, John P., Methods and apparatus for genetic evaluation.
    22. Duncan, David D.; Eshoo, Mark W., Methods and compositions for multiple displacement amplification of nucleic acids.
    23. Ecker, David J.; Sampath, Rangarajan; Blyn, Lawrence B.; Hofstadler, Steven A.; Hall, Thomas A., Methods for concurrent identification and quantification of an unknown bioagent.
    24. Ecker, David J.; Sampath, Rangarajan; Blyn, Lawrence B.; Hofstadler, Steven A.; Hall, Thomas A., Methods for concurrent identification and quantification of an unknown bioagent.
    25. Ecker, David J.; Sampath, Rangarajan; Blyn, Lawrence B.; Hofstadler, Steven A.; Hall, Thomas A., Methods for concurrent identification and quantification of an unknown bioagent.
    26. Ecker, David J.; Hofstadler, Steven A.; Sampath, Rangarajan; Blyn, Lawrence B.; Hall, Thomas A.; Massire, Christian, Methods for identification of coronaviruses.
    27. Hall, Thomas A.; Sampath, Rangarajan; Harpin, Vanessa; Hofstadler, Steven A.; Jiang, Yun, Methods for identification of sepsis-causing bacteria.
    28. Hall, Thomas A.; Sampath, Rangarajan; Harpin, Vanessa; Hofstadler, Steven A.; Jiang, Yun, Methods for identification of sepsis-causing bacteria.
    29. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Stephen A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Hall, Thomas A.; Jiang, Yun; Hannis, James C.; White, Neill; Samant, Vivek; Eshoo, Mark W.; Drader, Jared J., Methods for identifying bioagents.
    30. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven; McNeil, John; Crooke, Stanley T.; Hannis, James C., Methods for identifying bioagents.
    31. Hall, Thomas A.; Hofstadler, Steven A.; Sannes-Lowery, Kristin, Methods for rapid forensic DNA analysis.
    32. Hofstadler, Steven A.; Hall, Thomas A.; Ecker, David J.; Blyn, Lawrence B.; Eshoo, Mark W.; Samant, Vivek; White, Neill, Methods for rapid forensic analysis of mitochondrial DNA.
    33. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Hall, Thomas A.; Jiang, Yun; Hannis, James C.; White, Neil; Samant, Vivek; Eshoo, Mark W.; Drader, Jared J., Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy.
    34. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Hall, Thomas A.; Jiang, Yun; Hannis, James C.; White, Neill K.; Samant, Vivek; Eshoo, Mark W.; Drader, Jared J., Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy.
    35. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence; Hall, Thomas A.; Jiang, Yun; Hannis, James C.; White, Neill; Samant, Vivek; Eshoo, Mark W.; Drader, Jared James, Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy.
    36. Ecker, David J.; Hofstadler, Steven A.; Hall, Thomas A.; Lowery, Kristin Sannes, Methods for rapid identification and quantitation of nucleic acid variants.
    37. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T., Methods for rapid identification of pathogens in humans and animals.
    38. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Ranken, Raymond; Hall, Thomas A., Methods for rapid identification of pathogens in humans and animals.
    39. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Ranken, Raymond; Hall, Thomas A., Methods for rapid identification of pathogens in humans and animals.
    40. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence B.; Ranken, Raymond; Hall, Thomas A., Methods for rapid identification of pathogens in humans and animals.
    41. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T.; Blyn, Lawrence; Ranken, Ray; Hall, Thomas A., Methods for rapid identification of pathogens in humans and animals.
    42. Hofstadler, Steven A.; Cummins, Lendell L., Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture.
    43. Hofstadler, Steven A.; Cummins, Lendell L., Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture.
    44. Eshoo, Mark W., Methods for repairing degraded DNA.
    45. Eshoo, Mark W., Methods for repairing degraded DNA.
    46. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C.; Oberkramer, Kevin S.; Bergold, Ronald K., Microplate handling systems and related computer program products and methods.
    47. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C.; Oberkramer, Kevin S.; Bergold, Ronald K., Microplate handling systems and related computer program products and methods.
    48. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C., Mixing cartridges, mixing stations, and related kits, systems, and methods.
    49. Eshoo, Mark W.; Picuri, John; Phillipson, Curtis, Multiple displacement amplification.
    50. Wahlestedt, Claes, Natural antisense and non-coding RNA transcripts as drug targets.
    51. Wahlestedt, Claes, Natural antisense and non-coding RNA transcripts as drug targets.
    52. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C., Sample processing units, systems, and related methods.
    53. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C., Sample processing units, systems, and related methods.
    54. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C., Sample processing units, systems, and related methods.
    55. Hofstadler, Steven A.; Drader, Jared J.; Gutierrez, Jose R.; Gleason, Paul J.; Bare, Rex O.; Miller, Robert D.; Smith, Jeffrey C., Sample processing units, systems, and related methods.
    56. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T., Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby.
    57. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T., Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby.
    58. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T., Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby.
    59. Ecker, David J.; Hofstadler, Steven A.; Hall, Thomas A.; Sannes-Lowery, Kristin, Systems and methods for rapid identification of nucleic acid variants.
    60. Hofstadler, Steven A.; Gutierrez, Jose R.; Hannis, James C.; Drader, Jared J.; Bare, Rex O.; Smith, Jeffrey C.; Gleason, Paul J.; Nathanson, Jared; Bergold, Ronald K.; Miller, Robert D.; Oberkramer, Kevin S., Systems for bioagent indentification.
    61. Ecker, David J.; Griffey, Richard H.; Sampath, Rangarajan; Hofstadler, Steven A.; McNeil, John; Crooke, Stanley T., Systems for rapid identification of pathogens in humans and animals.
    62. Ecker, David J.; Eshoo, Mark W., Targeted whole genome amplification method for identification of pathogens.
    63. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP.
    64. Collard, Joseph; Khorkova Sherman, Olga, Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1.
    65. Collard, Joseph; Khorkova Sherman, Olga, Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ).
    66. Collard, Joseph; Khorkova Sherman, Olga, Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin.
    67. Collard, Joseph; Khorkova Sherman, Olga, Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN.
    68. Collard, Joseph; Khorkova Sherman, Olga, Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT.
    69. Collard, Joseph; Khorkova Sherman, Olga, Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA.
    70. Collard, Joseph; Khorkova Sherman, Olga, Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG.
    71. Collard, Joseph; Khorkova Sherman, Olga, Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG.
    72. Collard, Joseph; Khorkova Sherman, Olga, Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4.
    73. Collard, Joseph; Khorkova Sherman, Olga, Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4.
    74. Collard, Joseph; Khorkova Sherman, Olga, Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4.
    75. Collard, Joseph; Khorkova Sherman, Olga, Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1.
    76. Collard, Joseph; Khorkova Sherman, Olga, Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1.
    77. Collard, Joseph; Khorkova Sherman, Olga, Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1.
    78. Collard, Joseph; Khorkova Sherman, Olga, Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ).
    79. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos; Shen, Gang, Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA.
    80. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos; Shen, Gang, Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA.
    81. Collard, Joseph; Khorkova Sherman, Olga, Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene.
    82. Collard, Joseph; Khorkova Sherman, Olga, Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene.
    83. Collard, Joseph; Khorkova Sherman, Olga, Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene.
    84. Collard, Joseph; Khorkova, Olga, Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1.
    85. Collard, Joseph; Khorkova Sherman, Olga, Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1.
    86. Collard, Joseph; Khorkova Sherman, Olga, Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1.
    87. Collard, Joseph; Khorkova Sherman, Olga, Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1.
    88. Collard, Joseph; Khorkova Sherman, Olga, Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1.
    89. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF.
    90. Faghihi, Mohammad Ali; Coito, Carlos, Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF.
    91. Collard, Joseph; Khorkova Sherman, Olga, Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3.
    92. Collard, Joseph; Khorkova Sherman, Olga, Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3.
    93. Collard, Joseph; Khorkova Sherman, Olga, Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3.
    94. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1.
    95. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1.
    96. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG.
    97. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG.
    98. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG.
    99. Collard, Joseph; Khorkova Sherman, Olga, Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene.
    100. Collard, Joseph; Khorkova Sherman, Olga, Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene.
    101. Collard, Joseph; Khorkova Sherman, Olga, Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family.
    102. Collard, Joseph; Khorkova Sherman, Olga, Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family.
    103. Collard, Joseph; Khorkova Sherman, Olga, Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO.
    104. Collard, Joseph; Sherman, Olga Khorkova, Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO.
    105. Collard, Joseph; Khorkova Sherman, Olga, Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21.
    106. Collard, Joseph; Khorkova Sherman, Olga, Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21.
    107. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity.
    108. Collard, Joseph; Khorkova Sherman, Olga, Treatment of frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN.
    109. Collard, Joseph; Khorkova Sherman, Olga, Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF.
    110. Collard, Joseph; Khorkova Sherman, Olga, Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF.
    111. Collard, Joseph; Khorkova Sherman, Olga, Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS).
    112. Collard, Joseph; Khorkova Sherman, Olga, Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3).
    113. Collard, Joseph; Khorkova Sherman, Olga, Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8.
    114. Collard, Joseph; Sherman, Olga Khorkova, Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8.
    115. Collard, Joseph; Khorkova Sherman, Olga, Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1.
    116. Collard, Joseph; Khorkova Sherman, Olga, Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1.
    117. Collard, Joseph; Khorkova Sherman, Olga, Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA.
    118. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2.
    119. Collard, Joseph; Khorkova Sherman, Olga, Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1.
    120. Collard, Joseph; Khorkova Sherman, Olga, Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1.
    121. Collard, Joseph; Khorkova Sherman, Olga, Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene.
    122. Collard, Joseph; Khorkova Sherman, Olga, Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene.
    123. Collard, Joseph; Khorkova Sherman, Olga, Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1.
    124. Collard, Joseph; Khorkova Sherman, Olga, Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1.
    125. Collard, Joseph; Khorkova Sherman, Olga, Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1.
    126. Collard, Joseph; Khorkova Sherman, Olga, Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1.
    127. Collard, Joseph; Khorkova Sherman, Olga, Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor.
    128. Collard, Joseph; Khorkova Sherman, Olga, Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor.
    129. Collard, Joseph; Khorkova Sherman, Olga, Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG.
    130. Collard, Joseph; Khorkova Sherman, Olga, Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4.
    131. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos; De Leon, Belinda, Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT).
    132. Collard, Joseph; Khorkova Sherman, Olga; De Leon, Belinda; Coito, Carlos; Hsiao, Jane H., Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA.
    133. Collard, Joseph; Khorkova Sherman, Olga, Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3.
    134. Collard, Joseph; Khorkova Sherman, Olga, Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3.
    135. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP.
    136. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP.
    137. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2.
    138. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2.
    139. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63.
    140. Collard, Joseph; Khorkova Sherman, Olga, Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63.
    141. Collard, Joseph; Khorkova Sherman, Olga, Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2.
    142. Collard, Joseph; Khorkova Sherman, Olga, Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2.
    143. Collard, Joseph; Khorkova Sherman, Olga, Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF.
    144. Collard, Joseph; Sherman, Olga Khorkova, Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF.
    145. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of ‘C terminus of HSP70-interacting protein’ (CHIP)related diseases by inhibition of natural antisense transcript to CHIP.
    146. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIP.
    147. Collard, Joseph; Khorkova Sherman, Olga; Coito, Carlos, Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로